Facial Wasting

Medications for Facial Lipoatrophy

Other titles: Facial Fat reduction; Facial Wasting; Lipoatrophy, Facial

About Facial Lipoatrophy: Facial Lipoatrophy is the reduction of subcutaneous fat onto the surface area.

The following list of medications are used at the treatment of this condition, or somehow related to.

Drug name	Rx / OTC	Pregnancy	CSA	Reviews	Rating
Sculptra	Rx	N	N	Add review	0.0
Generic title: poly-l-lactic acid systemic Drug class: miscellaneous uncategorized agents For customers:

poly-l-lactic acid	Rx	N	N	Add review	0.0
Generic title: poly-l-lactic acid systemic Brand title: Sculptra Drug class: miscellaneous uncategorized agents For customers: For professionals: a z Drug Truth

Rx	Prescription Only
OTC	Over the Counter
Rx/OTC	Prescription or Over The Counter
Off Label	This drug may well not be accepted by the FDA for the treatment of the condition.

Pregnancy Category
A	sufficient and well-controlled studies have failed to demonstrate a risk to the embryo within the first trimester of pregnancy (also there`s no evidence of risk in later trimesters).
B	Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women.
C	Animal reproduction studies have shown an adverse effect in the fetus and there are no sufficient and well-controlled studies in humans, but possible benefits may warrant used in pregnant women despite potential risks.
D	There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may warrant used in pregnant women despite potential risks.
X	Studies in animals or humans have demonstrated fetal abnormalities and/or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with used in pregnant women clearly outweigh potential benefits.
N	FDA have not classified the drug.

Controlled Substances Act (CSA) Schedule
N	Is not subject to the Controlled Substances Act.
1	features a high potential for misuse. Has no accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2	features a high potential for misuse. Includes a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may cause severe physical or emotional dependence.
3	Has a potential for abuse less than individuals in programs 1 and 2. Includes a currently accepted medical use in treatment in the United States. Abuse may lead to physical dependence or high psychological dependence.
4	features a minimal potential for abuse in accordance with individuals in program 3. It`s a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in program 3.
5	features a minimal potential for abuse in accordance with individuals in program 4. Includes a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in program 4.

Infection
X	Interacts with Medication.

Always seek advice from your physician to ensure the information displayed on this page relates to your circumstances.